Olga Gavrilova
University of Kiel
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Olga Gavrilova.
Gut | 2011
Ateequr Rehman; Christian Sina; Olga Gavrilova; Robert Häsler; Stephan J. Ott; John F. Baines; Stefan Schreiber; Philip Rosenstiel
Objective The mammalian commensal gut microbiota is highly diverse and displays an individual-specific composition determined by host genotype and environmental factors. The temporal development of host–microbial homeostasis in the digestive tract is recognised as a major function of the immune system. However, the underlying cellular and molecular mechanisms are just beginning to come to light. Nucleotide-binding, oligomerisation domain 2 (NOD2) recognises bacterial muramyl dipeptide and is regarded as a pivotal sensor molecule of the intestinal barrier. The aim of this study was to investigate its influence on the development and composition of the intestinal microbiota using a Nod2-deficient mouse model. Methods The dynamics of faecal and ileal microbial composition were investigated in Nod2+/+and Nod2−/− mice on a C57BL/6J background. We assessed microbial diversity and composition using 16S ribosomal RNA gene-based clone library sequencing and high throughput pyrosequencing and quantified the observed changes by real-time PCR. Changes in the major bacterial phyla were investigated in human samples by quantitative real-time PCR. Results We found that adult Nod2-deficient mice display a substantially altered microbial community structure and a significantly elevated bacterial load in their faeces and terminal ileum compared to their wild-type counterparts. Interestingly, we demonstrate that these findings are also present in weaning mice, indicating a profound influence of Nod2 on the early development and composition of the intestinal microbiota. We demonstrate that NOD2 genotypes also influence the microbial composition in humans. Conclusions Our results point to an essential role of Nod2 for the temporal development and composition of the host microbiota, both in mice and in humans, which may contribute to the complex role of NOD2 for the aetiopathogenesis of Crohns disease.
Journal of Immunology | 2009
Christian Sina; Olga Gavrilova; Matti Förster; Andreas Till; Stefanie Derer; Friederike L. Hildebrand; Björn Raabe; Athena Chalaris; Jürgen Scheller; Ateequr Rehmann; Andre Franke; Stephan J. Ott; Robert Häsler; Susanna Nikolaus; Ulrich R. Fölsch; Stefan Rose-John; Hui-Ping Jiang; Jun Li; Stefan Schreiber; Philip Rosenstiel
Molecular danger signals attract neutrophilic granulocytes (polymorphonuclear leukocytes (PMNs)) to sites of infection. The G protein-coupled receptor (GPR) 43 recognizes propionate and butyrate and is abundantly expressed on PMNs. The functional role of GPR43 activation for in vivo orchestration of immune response is unclear. We examined dextrane sodium sulfate (DSS)-induced acute and chronic intestinal inflammatory response in wild-type and Gpr43-deficient mice. The severity of colonic inflammation was assessed by clinical signs, histological scoring, and cytokine production. Chemotaxis of wild-type and Gpr43-deficient PMNs was assessed through transwell cell chemotactic assay. A reduced invasion of PMNs and increased mortality due to septic complications were observed in acute DSS colitis. In chronic DSS colitis, Gpr43−/− animals showed diminished PMN intestinal migration, but protection against inflammatory tissue destruction. No significant difference in PMN migration and cytokine secretion was detected in a sterile inflammatory model. Ex vivo experiments show that GPR43-induced migration is dependent on activation of the protein kinase p38α, and that this signal acts in cooperation with the chemotactic cytokine keratinocyte chemoattractant. Interestingly, shedding of L-selectin in response to propionate and butyrate was compromised in Gpr43−/− mice. These results indicate a critical role for GPR43-mediated recruitment of PMNs in containing intestinal bacterial translocation, yet also emphasize the bipotential role of PMNs in mediating tissue destruction in chronic intestinal inflammation.
Journal of Experimental Medicine | 2010
Athena Chalaris; Nina Adam; Christian Sina; Philip Rosenstiel; Judith Lehmann-Koch; Peter Schirmacher; Dieter Hartmann; Joanna Cichy; Olga Gavrilova; Stefan Schreiber; Thomas Jostock; Vance B. Matthews; Robert Häsler; Christoph Becker; Markus F. Neurath; Karina Reiß; Paul Saftig; Jürgen Scheller; Stefan Rose-John
The protease a disintegrin and metalloprotease (ADAM) 17 cleaves tumor necrosis factor (TNF), L-selectin, and epidermal growth factor receptor (EGF-R) ligands from the plasma membrane. ADAM17 is expressed in most tissues and is up-regulated during inflammation and cancer. ADAM17-deficient mice are not viable. Conditional ADAM17 knockout models demonstrated proinflammatory activities of ADAM17 in septic shock via shedding of TNF. We used a novel gene targeting strategy to generate mice with dramatically reduced ADAM17 levels in all tissues. The resulting mice called ADAM17ex/ex were viable, showed compromised shedding of ADAM17 substrates from the cell surface, and developed eye, heart, and skin defects as a consequence of impaired EGF-R signaling caused by failure of shedding of EGF-R ligands. Unexpectedly, although the intestine of unchallenged homozygous ADAM17ex/ex mice was normal, ADAM17ex/ex mice showed substantially increased susceptibility to inflammation in dextran sulfate sodium colitis. This was a result of impaired shedding of EGF-R ligands resulting in failure to phosphorylate STAT3 via the EGF-R and, consequently, in defective regeneration of epithelial cells and breakdown of the intestinal barrier. Besides regulating the systemic availability of the proinflammatory cytokine TNF, our results demonstrate that ADAM17 is needed for vital regenerative activities during the immune response. Thus, our mouse model will help investigate ADAM17 as a potential drug target.
PLOS ONE | 2012
Kirstin Reinecke; Sevgi Eminel; Franziska Dierck; Wibke Roessner; Sabine Kersting; Ansgar M. Chromik; Olga Gavrilova; Ale Laukevicience; Ivo Leuschner; Vicki Waetzig; Philip Rosenstiel; Thomas Herdegen; Christian Sina
The c-Jun N-terminal kinase (JNK)-inhibiting peptide D-JNKI-1, syn. XG-102 was tested for its therapeutic potential in acute inflammatory bowel disease (IBD) in mice. Rectal instillation of the chemical irritant trinitrobenzene sulfonic acid (TNBS) provoked a dramatic acute inflammation in the colon of 7–9 weeks old mice. Coincident subcutaneous application of 100 µg/kg XG-102 significantly reduced the loss of body weight, rectal bleeding and diarrhoea. After 72 h, the end of the study, the colon was removed and immuno-histochemically analysed. XG-102 significantly reduced (i) pathological changes such as ulceration or crypt deformation, (ii) immune cell pathology such as infiltration and presence of CD3- and CD68-positive cells, (iii) the production of tumor necrosis factor (TNF)-α in colon tissue cultures from TNBS-treated mice, (iv) expression of Bim, Bax, FasL, p53, and activation of caspase 3, (v) complexation of JNK2 and Bim, and (vi) expression and activation of the JNK substrate and transcription factor c-Jun. A single application of subcutaneous XG-102 was at least as effective or even better depending on the outcome parameter as the daily oral application of sulfasalazine used for treatment of IBD. The successful and substantial reduction of the severe, TNBS-evoked intestinal damages and clinical symptoms render the JNK-inhibiting peptide XG-102 a powerful therapeutic principle of IBD.
Inflammatory Bowel Diseases | 2010
Christian Sina; Alexander Arlt; Olga Gavrilova; Emilie Midtling; Marie Luise Kruse; Susanne Sebens Müerköster; Rajiv Kumar; Ulrich R. Fölsch; Stefan Schreiber; Philip Rosenstiel
Background: Inflammatory bowel diseases (IBDs) result from environmental and genetic factors and are characterized by an imbalanced immune response in the gut and deregulated activation of the transcription factor NF‐&kgr;B. Addressing the potential role of gly96/iex‐1 in the regulation of NF‐&kgr;B in IBD, we used the dextran sodium sulfate (DSS) colitis model in mice in which the gly96/iex‐1 gene had been deleted. Methods: C57BL/6 mice of gly96/iex‐1−/− or gly96/iex‐1+/+ genotype were treated continuously with 4% DSS (5 days) and repeatedly with 2% DSS (28 days) for inducing acute and chronic colitis, respectively. In addition to clinical and histological exploration, colon organ culture and bone marrow‐derived cells (BMCs) were analyzed for chemo/cytokine expression and NF‐&kgr;B activation. Results: Compared to wildtype littermates, gly96/iex‐1−/− mice exhibited an aggravated phenotype of both acute and chronic colitis, along with a greater loss of body weight and colon length. Colonic endoscopy revealed a higher degree of hyperemia, edema, and bleeding in gly96/iex‐1−/− mice, and immunohistochemistry detected massive mucosal infiltration of leukocytes and marked histological changes. The expression of proinflammatory chemo‐ and cytokines was higher in the colon of DSS‐treated gly96/iex‐1−/− mice, and the NF‐&kgr;B activation was enhanced particularly in the distal colon. In cultured BMCs from gly96/iex‐1−/− mice, Pam3Cys4 treatment induced expression of proinflammatory mediators to a higher degree than in gly96/iex‐1+/+ BMCs, along with greater NF‐&kgr;B activation. Conclusions: Based on the observation that genetic ablation of gly96/iex‐1 triggers intestinal inflammation in mice, we demonstrate for the first time that gly96/iex‐1 exerts strong antiinflammatory activity via its NF‐&kgr;B‐counterregulatory effect. (Inflamm Bowel Dis 2009;)
Gut | 2013
Christian Sina; Simone Lipinski; Olga Gavrilova; Konrad Aden; Ateequr Rehman; Andreas Till; Andrea Rittger; Rainer Podschun; Ulf Meyer-Hoffert; Robert Haesler; Emilie Midtling; Katrin Pütsep; Michael A. McGuckin; Stefan Schreiber; Paul Saftig; Philip Rosenstiel
Objective Cathepsin K is a lysosomal cysteine protease that has pleiotropic roles in bone resorption, arthritis, atherosclerosis, blood pressure regulation, obesity and cancer. Recently, it was demonstrated that cathepsin K-deficient (Ctsk−/− ) mice are less susceptible to experimental autoimmune arthritis and encephalomyelitis, which implies a functional role for cathepsin K in chronic inflammatory responses. Here, the authors address the relevance of cathepsin K in the intestinal immune response during chronic intestinal inflammation. Design Chronic colitis was induced by administration of 2% dextran sodium sulphate (DSS) in distilled water. Mice were assessed for disease severity, histopathology and endoscopic appearance. Furthermore, DSS-exposed Ctsk−/− mice were treated by rectal administration of recombinant cathepsin K. Intestinal microflora was assessed by real-time PCR and 16srDNA molecular fingerprinting of ileal and colonic mucosal and faecal samples. Results Using Ctsk−/− mice, the authors demonstrate a protective role of cathepsin K against chronic DSS colitis. Dissecting the underlying mechanisms the authors found cathepsin K to be present in intestinal goblet cells and the mucin layer. Furthermore, a direct cathepsin K-mediated bactericidal activity against intestinal bacteria was demonstrated, which potentially explains the alteration of intestinal microbiota observed in Ctsk−/− mice. Rectal administration of recombinant cathepsin K in DSS-treated Ctsk−/− mice ameliorates the severity of intestinal inflammation. Conclusion These data identify extracellular cathepsin K as an intestinal antibacterial factor with anti-inflammatory potential and suggest that topical administration of cathepsin K might provide a therapeutic option for patients with inflammatory bowel disease.
BMC Genomics | 2011
Ulrich C. Klostermeier; Matthias Barann; Michael Wittig; Robert Häsler; Andre Franke; Olga Gavrilova; Benjamin Kreck; Christian Sina; Markus Schilhabel; Stefan Schreiber; Philip Rosenstiel
BackgroundThe intestinal mucosa is characterized by complex metabolic and immunological processes driven highly dynamic gene expression programs. With the advent of next generation sequencing and its utilization for the analysis of the RNA sequence space, the level of detail on the global architecture of the transcriptome reached a new order of magnitude compared to microarrays.ResultsWe report the ultra-deep characterization of the polyadenylated transcriptome in two closely related, yet distinct regions of the mouse intestinal tract (small intestine and colon). We assessed tissue-specific transcriptomal architecture and the presence of novel transcriptionally active regions (nTARs). In the first step, signatures of 20,541 NCBI RefSeq transcripts could be identified in the intestine (74.1% of annotated genes), thereof 16,742 are common in both tissues. Although the majority of reads could be linked to annotated genes, 27,543 nTARs not consistent with current gene annotations in RefSeq or ENSEMBL were identified. By use of a second independent strand-specific RNA-Seq protocol, 20,966 of these nTARs were confirmed, most of them in vicinity of known genes. We further categorized our findings by their relative adjacency to described exonic elements and investigated regional differences of novel transcribed elements in small intestine and colon.ConclusionsThe current study demonstrates the complexity of an archetypal mammalian intestinal mRNA transcriptome in high resolution and identifies novel transcriptionally active regions at strand-specific, single base resolution. Our analysis for the first time shows a strand-specific comparative picture of nTARs in two tissues and represents a resource for further investigating the transcriptional processes that contribute to tissue identity.
Gastroenterology | 2012
Simone Lipinski; Christian Sina; Konrad Aden; Olga Gavrilova; Andreas Till; Ulf Meyer-Hoffert; Rainer Podschun; Andrea Rittger; Robert Haesler; Ateequr Rehman; Katrin Pütsep; Stefan Schreiber; Paul Saftig; Philip Rosenstiel
Journal of Cell Biology | 2010
Athena Chalaris; Nina Adam; Christian Sina; Philip Rosenstiel; Judith Lehmann-Koch; Peter Schirmacher; Dieter Hartmann; Joanna Cichy; Olga Gavrilova; Stefan Schreiber; Thomas Jostock; Vance B. Matthews; Robert Häsler; Christoph Becker; Markus F. Neurath; Karina Reiß; Paul Saftig; Jürgen Scheller; Stefan Rose-John
Gastroenterology | 2010
Christian Sina; Ateequr Rehmann; Olga Gavrilova; Mathias Chamaillard; John F. Baines; Stefan Schreiber; Philip Rosenstiel